These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36637349)

  • 1. Phenotype Switching in Glioblastoma Promotes Therapy Escape.
    Cancer Discov; 2023 Mar; 13(3):525. PubMed ID: 36637349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity.
    Villatoro AJ; Alcoholado C; Martín-Astorga MDC; Rubio N; Blanco J; Garrido CP; Becerra J
    PLoS One; 2022; 17(2):e0264001. PubMed ID: 35167620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
    Parsa AT
    World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
    [No Abstract]   [Full Text] [Related]  

  • 4. HSP27 protects against ferroptosis of glioblastoma cells.
    Yuan F; Sun Q; Zhang S; Ye L; Xu Y; Xu Z; Liu B; Zhang S; Chen Q
    Hum Cell; 2022 Jan; 35(1):238-249. PubMed ID: 34791597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
    Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
    Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy of glioblastoma].
    Astrup J
    Ugeskr Laeger; 2001 Apr; 163(15):2147. PubMed ID: 11332215
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonal diversity in glioblastoma: is it clinically relevant?
    Watts C; Piccirillo SG
    Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A silver lining on the horizon for glioblastoma.
    Knisely JP; Baehring JM
    Lancet Oncol; 2009 May; 10(5):434-5. PubMed ID: 19410186
    [No Abstract]   [Full Text] [Related]  

  • 9. EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation.
    Gursel DB; Schlaff CD; Boockvar JA
    Neurosurgery; 2012 Oct; 71(4):N17-8. PubMed ID: 22989968
    [No Abstract]   [Full Text] [Related]  

  • 10. Solving the riddle of glioblastoma: The hope for immunotherapy.
    Bashir R; Mohile NA
    Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic landscape of glioblastoma and the potential clinical utility.
    Wang CJ; Choe KS
    CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma.
    Festuccia C; Gravina GL
    Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in epigenetic glioblastoma therapy.
    Lee DH; Ryu HW; Won HR; Kwon SH
    Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
    Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure following gene therapy for recurrent glioblastoma multiforme?
    Karabatsou K; Bernstein M
    Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of immunotherapy resistance: lessons from glioblastoma.
    Jackson CM; Choi J; Lim M
    Nat Immunol; 2019 Sep; 20(9):1100-1109. PubMed ID: 31358997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line.
    Veselska R; Skoda J; Loja T; Zitterbart K; Pavelka Z; Smardova J; Valaskova I; Hermanova M; Sterba J
    Childs Nerv Syst; 2010 Jun; 26(6):841-6. PubMed ID: 20195615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.